swollen arm/swollenness in the arm; fatigue; chills; body aches; pain in the upper back/Upper back pain; chest pain; had fever for 1 night/running fever; joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 17-year-old female patient received meningococcal group b Rlp2086 (TRUMENBA), in Oct2022 as dose 1, single (Lot number: Unknown) at the age of 17 years, in left arm for immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PAIN (non-serious) with onset Oct2022, outcome "unknown", described as "body aches"; CHEST PAIN (non-serious) with onset Oct2022, outcome "unknown"; CHILLS (non-serious) with onset Oct2022, outcome "unknown"; FATIGUE (non-serious) with onset Oct2022, outcome "unknown"; PYREXIA (non-serious) with onset Oct2022, outcome "unknown", described as "had fever for 1 night/running fever"; ARTHRALGIA (non-serious) with onset Oct2022, outcome "unknown", described as "joint pain"; BACK PAIN (non-serious) with onset Oct2022, outcome "recovered" (Oct2022), described as "pain in the upper back/Upper back pain"; PERIPHERAL SWELLING (non-serious) with onset Oct2022, outcome "unknown", described as "swollen arm/swollenness in the arm". Therapeutic measures were not taken as a result of peripheral swelling, fatigue, chills, pain, back pain, chest pain, pyrexia, arthralgia.  Additional information: The report was not related to a study or programme. The reporter reported the patient experienced with the meningococcal group b Rlp2086 was similar to the Pfizer Covid-19 vaccine, stating "she almost didn't have the exact same symptoms as the Covid vaccine, swollenness in the arm, and chest pain, and running fever and a little fatigue". The reporter was asking if the meningococcal group b Rlp2086 vaccine was a mRNA vaccine because the patient had a similar reaction to the Covid Vaccine, a swollen arm and fatigue. The reporter stated that the patient received the meningococcal group b Rlp2086 Vaccine 9 or 10 days ago and was totally fine now. The reporter stated that the patient had a swollen arm, fatigue, chills, body aches, pain in the upper back. The reporter stated that the pain in the upper back seemed bizarre and had the reporter worried because she known people had that kind of pain with a heart attack. The reporter was probed for outcome and time frame for all the patient's symptoms but replied only with saying that the patient's upper back pain only lasted a couple of hours. The patient then stated that the patient also had joint pain. The reporter stated that the patient would have to get the vaccination again within 6 months or starting college. The patient wanted to know whether it was recommended that the patient get it again with these reactions. The patient denied any other medications, medical conditions, labs, testing, or treatments for the patient relevant to these events. Relevant tests was none. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was none. Additional vaccines administered on same date of the Pfizer Suspect was none. The patient had not received any other vaccines within 4 weeks prior to the first administration date of the suspect vaccine(s). The patient want to know whether it was normal to have a swollen arm, fatigue, joint pain, chills and body aches after meningococcal group b Rlp2086.   The information on the batch/lot number for meningococcal group b Rlp2086 has been requested and will be submitted if and when received.